Hasan – Dermapharm Co. Ltd.

With the ambition of becoming a leading generic drug manufacturer in Vietnam, HASAN – DERMAPHARM is one of the pharmaceutical companies with the most rapid growth. Indeed, Hasan Dermapharma is one of 32 to have received the prestigious “Vietnamese Medicine Star” award. 

1. Overview

Established in 2004, HASAN – DERMAPHARM is one of the pioneer companies in Vietnam certified by WHO-GMP, GLP, and GSP. The first factory was built based on a joint venture with Dermapharm AG, headquartered in Munich, Germany.

Through more than 10 years of growing the business, HASAN – DERMAPHARM has four major advantages that help it stand out in the pharmaceutical market.

• Technology transferred from the Dermapharm AG group
• The European standards lab
• Expertise with bioequivalence studies
• Extensive distribution networks

2. Research & Production of HASAN – DERMAPHARM

With over 400 product registration numbers, the company can produce a variety of dosage forms such as liquid, solid, and semi-solid pharmaceuticals, as well as specialty pharmaceuticals at affordable prices using more than 100 active ingredients. Four major categories are including cardiovascular, neurological, diabetic, and dyslipidemia.

HASAN – DERMAPHARM‘s R&D department developed according to European standards, including technology and a German team of professionals. The company has successfully researched and developed high-quality pharmaceuticals with extended-release dosage forms such as Nifedipine Hasan 20 Retard, Glisan 30 MR, Vashasan 35 MR, and micronized dosage forms such as Hafenthyl 200, Hafenthyl Supra 160, Hasanflon 500.

3. Development cooperation of HASAN – DERMAPHARM

The Mibe GmbH Arzneimittel pharmaceutical factory of Dermapharm AG – the parent company of Hasan-Dermapharm  – has the most advanced and modern technological lines in Germany, responsible for the production of more than 300 products for the group.

Hasan-Dermapharm has manufactured franchise products from Mibe GmbH Arzneimittel & Acis Arzneimittel GmbH – 02 subsidiaries of Dermapharm AG with more than 20 products such as Ambelin 5mg, Ambelin 10mg, Enamigal 5mg, Enamigal 10mg, Predsantyl 4mg, Predsantyl 16mg and Imidu 60.

4. Strategies and Objectives

HASAN – DERMAPHARM is now building a new plant following EU-GMP standards to compete with about thirty other Vietnamese manufacturers in the EU-GMP race.

To become a leading generic drug company in Vietnam to provide European-quality pharmaceuticals to consumers, HASAN – DERMAPHARM has focused on 05 strategies:

• Improving the management system
• Personnel training and human resource development
• Focusing on researching new products while improving product quality and production capacity.
• Improving marketing and brand building for HASAN – DERMAPHARM
• Build a strong organizational culture for HASAN – DERMAPHARM

REFERENCES:

Công ty TNHH Hasan – Dermapharm